| Contactins in the central nervous system: role in health and disease M Chatterjee, D Schild, CE Teunissen Neural regeneration research 14 (2), 206-216, 2019 | 61 | 2019 |
| α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease SA Stuendl A, Kraus T, Chatterjee M, Zapke B, Sadowski B, Moebius W, Hobert ... Movement Disorders, 2021 | 50* | 2021 |
| Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia A Chakraborty, M Chatterjee, H Twaalfhoven, M Del Campo Milan, ... Alzheimer's research & therapy 10, 1-7, 2018 | 34 | 2018 |
| Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease M Chatterjee, M Del Campo, THJ Morrema, M de Waal, WM van der Flier, ... Alzheimer's Research & Therapy 10, 1-11, 2018 | 28 | 2018 |
| Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis CET Madhurima Chatterjee, Marleen JA Koel-Simmelink, Inge MW Verberk, Joep ... Multiple Sclerosis Journal- Experimental, Translational and Clinical, 2018 | 25 | 2018 |
| Detection of contactin-2 in cerebrospinal fluid (CSF) of patients with Alzheimer's disease using Fluorescence Correlation Spectroscopy (FCS) M Chatterjee, B Nöding, EAJ Willemse, MJA Koel-Simmelink, ... Clinical biochemistry 50 (18), 1061-1066, 2017 | 18 | 2017 |
| Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis ZYGJ van Lierop, L Wieske, MJA Koel-Simmelink, M Chatterjee, I Dekker, ... Multiple Sclerosis Journal 28 (1), 102-110, 2022 | 15 | 2022 |
| Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies CET Madhurima Chatterjee, Inger van Steenoven, Evelien Huisman, Linda ... Biomolecules 1177 (10(8)), 2020 | 13 | 2020 |
| C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study M Chatterjee, S Özdemir, M Kunadt, M Koel‐Simmelink, W Boiten, ... Alzheimer's & Dementia 19 (11), 4828-4840, 2023 | 6 | 2023 |
| Serum contactin-1 in CIDP: A cross-sectional study L Wieske, L Martín-Aguilar, J Fehmi, C Lleixà, MJA Koel-Simmelink, ... Neurology: Neuroimmunology & Neuroinflammation 8 (5), e1040, 2021 | 5 | 2021 |
| Contactins & Alzheimer’s Disease: Synaptic Proteins, Contactins may Contribute to the Pathology of Alzheimer’s Disease M Chatterjee, C Teunissen Neuroscience 424, 182-183, 2020 | 3 | 2020 |
| Proteome encoded determinants of protein sorting into extracellular vesicles SA Katharina Waury, ProfileDea Gogishvili, Rienk Nieuwland, Madhurima ... Journal of Extracellular Biology, 2024 | 2* | 2024 |
| [P2–249]: CONTACTIN‐1 IN CSF DISCRIMINATES DEMENTIA WITH LEWY BODIES (DLB) FROM AD AND NON‐DEMENTED CONTROLS M Chatterjee, AW Lemstra, I van Steenoven, WM van der Flier, ... Alzheimer's & Dementia 13 (7S_Part_14), P708-P708, 2017 | 2 | 2017 |
| Effect of Adeno‐associated Viral Vector Mediated APOE Protective Variants Expression on Tau Pathology in a Tau Mouse Model M Chatterjee, A Zuko, H Wattimury, L Boggiani, L Paerels, L Schwarz, ... Alzheimer's & Dementia 19, e076264, 2023 | | 2023 |
| P‐tau217 is the earliest plasma marker of dementia of the Alzheimer’s type in older primary care patients L Kleineidam, S Oezdemir, P Martino‐Adami, L Weinhold, D Koehler, ... Alzheimer's & Dementia 19, e082929, 2023 | | 2023 |
| Performance of Alzheimer’s disease plasma biomarkers in primary care: results from the AgeCoDe study P Martino‐Adami, M Chatterjee, L Kleineidam, M Pentzek, S Weyerer, ... Alzheimer's & Dementia 19, e082595, 2023 | | 2023 |
| Plasma extracellular vesicle Tau isoform ratios and TDP-43 inform about molecular pathology in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis and 66 more Madhurima Chatterjee, Selcuk Özdemir, Christian Fritz, Wiebke Möbius Research Square, 2023 | | 2023 |
| Contactins as novel potential biomarkers for Alzheimer's disease, Parkinson's disease and Multiple sclerosis: Emerging Synaptic Biomarkers for Neurodegenerative Diseases M Chatterjee | | 2020 |
| O1‐10‐06: CONTACTIN‐1 HAS ADDED VALUE FOR DISCRIMINATION OF DEMENTIA WITH LEWY BODIES FROM ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE M Chatterjee, I van Steenoven, L Oosterveld, WM Van der Flier, ... Alzheimer's & Dementia 14 (7S_Part_4), P245-P246, 2018 | | 2018 |
| P2‐248: CONTACTIN‐2 AS A POTENTIAL BIOMARKER FOR MILD COGNITIVE IMPAIRMENT V Gupta, M Chatterjee, BM Tijms, FA de Leeuw, P Scheltens, ... Alzheimer's & Dementia 14 (7S_Part_14), P768-P768, 2018 | | 2018 |
Anja SchneiderDZNE Bonn, UKB BonnVerified email at gwdg.de
